This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignees: Samsung Life Public Welfare Foundation, Sungkyunkwan University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2022
Title: Innovations of Eun Hee Kim in Stem Cell Research
Introduction
Eun Hee Kim is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of stem cell research, particularly in the development of microvesicles derived from stem cells. Her innovative work focuses on enhancing the efficacy of these microvesicles for therapeutic applications.
Latest Patents
Eun Hee Kim holds a patent for "Stem cell-derived microvesicles with enhanced efficacy, use thereof, and method for enhancing efficacy." This invention relates to stem cell-derived microvesicles that have an enhanced expression level of microRNAs. These microvesicles are intended for the prevention or treatment of stroke. The method described in the patent promotes the production of microRNAs and microvesicles, enhancing the efficacy of stem cells. This innovative approach allows for the efficient production of therapeutic microRNAs in large quantities, making them valuable for research and clinical applications.
Career Highlights
Throughout her career, Eun Hee Kim has worked with notable organizations, including the Samsung Life Public Welfare Foundation and Sungkyunkwan University. Her experience in these institutions has contributed to her expertise in stem cell research and innovation.
Collaborations
Eun Hee Kim has collaborated with esteemed colleagues such as Oh Young Bang and Jae Min Cha. These partnerships have furthered her research and development efforts in the field of stem cell-derived microvesicles.
Conclusion
Eun Hee Kim's contributions to stem cell research through her innovative patents and collaborations highlight her role as a leading inventor in this vital area of medical science. Her work promises to advance therapeutic options for stroke and other conditions, showcasing the potential of stem cell-derived microvesicles in clinical settings.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile